Monografie
EpCAM CAR T cells for the treatment of lung cancer brain metastasis - an in vivo imaging study in the mouse
- Sprache
-
Englisch
- Identifier
-
1308694091
Thema
Tiermodell; Immuntherapie; Krebs; Tumorwachstum; Apoptosis; T-Lymphozyt
Beteiligte Personen und Organisationen
- DOI
-
10.5282/edoc.30804
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
09.01.2024, 09:53 MEZ
Objekttyp
- Monografie
Ähnliche Objekte (12)
Elucidating the effect of anti-VEGF-A and anti-ANG-2 in combination with immunecheckpoint inhibition targeted treatment in small cell lung cancer
Establishment of a human CD22-transgenic lymphoma mouse model to study immunotherapies in organ-specific tumor microenvironments
A screening for novel immune-checkpoints identifies CAMK1D as a kinase responsible for immune resistance in multiple myeloma
Characterizing the tumor microenvironment upon transcutaneous immunization by single-cell RNA-sequencing - implications for cancer immunotherapy
Einfluss von CD25+ regulatorischen T-Zellen auf die therapeutische Effektivität tumorspezifischer T-Zellen nach LRAST (Lymphodepletion, Rekonstitution und aktiv-spezifischer Tumortherapie) in einem murinen Melanom-Modell
Tumor-infiltrating lymphocytes as biomarkers to monitor local ablation of primary and secondary liver cancer
Metabolic engineering of murine cytotoxic T cells by solute carrier Slc2a1/GLUT1 overexpression to enhance anti-tumor activity
Frequency, phenotype and clinical relevance of dendritic cells and T cells in colorectal cancer and pancreatic ductal adenocarcinoma and their therapeutic modulation
Endogenous antigen-specific T and B cell immune responses in cancer and invasive infections are frequent, but often limited by potentially targetable immune escape mechanisms
Synthetic agonistic receptor T-Zellen in Kombination mit den bispezifischen Antikörpern anti-EGFRvIII x anti-TYRP1 und anti-EGFRvIII x anti-MCSP zur Behandlung maligner Melanomzellen in vitro
Die kombinierte Expression der Chemokinrezeptoren CCR4 und CXCR6 in CD8-positiven Ovalbumin-spezifischen T-Lymphozyten zur Verbesserung der adoptiven T-Zell Therapie in einem murinen Pankreaskarzinom-Modell
Immunevasion in einem endogenen B-Zell-Lymphommodell: Die Rolle regulatorischer T-Zellen und Möglichkeiten der therapeutischen Modulation
Elucidating the effect of anti-VEGF-A and anti-ANG-2 in combination with immunecheckpoint inhibition targeted treatment in small cell lung cancer
Establishment of a human CD22-transgenic lymphoma mouse model to study immunotherapies in organ-specific tumor microenvironments
A screening for novel immune-checkpoints identifies CAMK1D as a kinase responsible for immune resistance in multiple myeloma
Characterizing the tumor microenvironment upon transcutaneous immunization by single-cell RNA-sequencing - implications for cancer immunotherapy
Einfluss von CD25+ regulatorischen T-Zellen auf die therapeutische Effektivität tumorspezifischer T-Zellen nach LRAST (Lymphodepletion, Rekonstitution und aktiv-spezifischer Tumortherapie) in einem murinen Melanom-Modell
Tumor-infiltrating lymphocytes as biomarkers to monitor local ablation of primary and secondary liver cancer
Metabolic engineering of murine cytotoxic T cells by solute carrier Slc2a1/GLUT1 overexpression to enhance anti-tumor activity
Frequency, phenotype and clinical relevance of dendritic cells and T cells in colorectal cancer and pancreatic ductal adenocarcinoma and their therapeutic modulation
Endogenous antigen-specific T and B cell immune responses in cancer and invasive infections are frequent, but often limited by potentially targetable immune escape mechanisms
Synthetic agonistic receptor T-Zellen in Kombination mit den bispezifischen Antikörpern anti-EGFRvIII x anti-TYRP1 und anti-EGFRvIII x anti-MCSP zur Behandlung maligner Melanomzellen in vitro
Die kombinierte Expression der Chemokinrezeptoren CCR4 und CXCR6 in CD8-positiven Ovalbumin-spezifischen T-Lymphozyten zur Verbesserung der adoptiven T-Zell Therapie in einem murinen Pankreaskarzinom-Modell
Immunevasion in einem endogenen B-Zell-Lymphommodell: Die Rolle regulatorischer T-Zellen und Möglichkeiten der therapeutischen Modulation
Elucidating the effect of anti-VEGF-A and anti-ANG-2 in combination with immunecheckpoint inhibition targeted treatment in small cell lung cancer
Establishment of a human CD22-transgenic lymphoma mouse model to study immunotherapies in organ-specific tumor microenvironments
A screening for novel immune-checkpoints identifies CAMK1D as a kinase responsible for immune resistance in multiple myeloma
Characterizing the tumor microenvironment upon transcutaneous immunization by single-cell RNA-sequencing - implications for cancer immunotherapy
Einfluss von CD25+ regulatorischen T-Zellen auf die therapeutische Effektivität tumorspezifischer T-Zellen nach LRAST (Lymphodepletion, Rekonstitution und aktiv-spezifischer Tumortherapie) in einem murinen Melanom-Modell
Tumor-infiltrating lymphocytes as biomarkers to monitor local ablation of primary and secondary liver cancer
Metabolic engineering of murine cytotoxic T cells by solute carrier Slc2a1/GLUT1 overexpression to enhance anti-tumor activity
Frequency, phenotype and clinical relevance of dendritic cells and T cells in colorectal cancer and pancreatic ductal adenocarcinoma and their therapeutic modulation
Endogenous antigen-specific T and B cell immune responses in cancer and invasive infections are frequent, but often limited by potentially targetable immune escape mechanisms
Synthetic agonistic receptor T-Zellen in Kombination mit den bispezifischen Antikörpern anti-EGFRvIII x anti-TYRP1 und anti-EGFRvIII x anti-MCSP zur Behandlung maligner Melanomzellen in vitro
Die kombinierte Expression der Chemokinrezeptoren CCR4 und CXCR6 in CD8-positiven Ovalbumin-spezifischen T-Lymphozyten zur Verbesserung der adoptiven T-Zell Therapie in einem murinen Pankreaskarzinom-Modell